8 articles in this category
The journey from a promising stem cell line to a commercial therapy often stalls not on biology but on engineering: how do we grow enough cells, consi...
Scaffold-based tissue engineering is a field where the final construct is only as good as the process that built it. Many labs focus on material selec...
Cell therapy has moved from a laboratory curiosity to a regulated therapeutic modality, but the path from a petri dish to a patient's bloodstream is f...
Every biopharmaceutical program begins with a molecule and a vision, but the path from discovery to clinic is anything but linear. Teams face a maze o...
Bringing a new therapeutic from a research concept to a marketed product is one of the most complex, capital-intensive undertakings in modern science....
Every medical biotechnology project starts with a vision—a new therapy, a faster diagnostic, a more precise delivery system. But the path from idea to...
Personalized medicine promises to replace one-size-fits-all treatments with therapies matched to each patient's biology. But making that promise real ...
Biologics—large, complex proteins engineered from living cells—have moved from experimental therapies to standard-of-care treatments for autoimmune di...